Wolfgang Jungraithmayr, MD PhD, is
Chair of Thoracic Surgery at University Medicine Rostock, Germany. He received his
training in general thoracic surgery and lung transplantation at the University
Hospital Zurich, Switzerland, completed by fellowships at the University
Hospital Odense, Danmark and at Massachusetts General Hospital at Boston, US.
After obtaining his MD degree in
2000, he received his PhD from the University and ETH Zurich in 2010. At
University Rostock, he is leading research groups in tumor and transplantation
research. His team employs mouse models of lung cancer and the mouse model of
orthotopic lung transplantation that Jungraithmayr introduced for the first
time. The mouse model of lung transplantation provides great potential with
cross-departmental function, capable to answer research questions in transplant
and tumor immunology. By giving mouse lung transplant courses, Jungraithmayr´s
group teaches the transplant model for many years to international research
groups around the world.
The focus of his current tumor
research is to find new therapeutic strategies against lung cancer. Jungraithmayr´s
team identify the molecule CD26 to be overexpressed in lung adenocarcinomas
thus making it an attractive tumor target.
Wolfgang Jungraithmayr receives
continuous funding, mainly by the German Research Foundation and Swiss National
Science Foundation. So far, he received 16 national and international research
awards.
Wolfgang Jungraithmayr, MD PhD, is
Chair of Thoracic Surgery at University Medicine Rostock, Germany. He received his
training in general thoracic surgery and lung transplantation at the University
Hospital Zurich, Switzerland, completed by fellowships at the University
Hospital Odense, Danmark and at Massachusetts General Hospital at Boston, US.
After obtaining his MD degree in
2000, he received his PhD from the University and ETH Zurich in 2010. At
University Rostock, he is leading research groups in tumor and transplantation
research. His team employs mouse models of lung cancer and the mouse model of
orthotopic lung transplantation that Jungraithmayr introduced for the first
time. The mouse model of lung transplantation provides great potential with
cross-departmental function, capable to answer research questions in transplant
and tumor immunology. By giving mouse lung transplant courses, Jungraithmayr´s
group teaches the transplant model for many years to international research
groups around the world.
The focus of his current tumor
research is to find new therapeutic strategies against lung cancer. Jungraithmayr´s
team identify the molecule CD26 to be overexpressed in lung adenocarcinomas
thus making it an attractive tumor target.
Wolfgang Jungraithmayr receives
continuous funding, mainly by the German Research Foundation and Swiss National
Science Foundation. So far, he received 16 national and international research
awards.